Ajanta Pharma looking good
The stock has taken a support at 2175 around and can go upwards from here.
Talking about fundamental analysis, the stock has a net profit margin which fluctuates between 15-20% on yearly basis which is good for investment. The revenue has been increasing continuously for the past 5 years and the net profit looks good too.
Talking about the technical analysis, the stock is not in the overbought zone and has taken a support on the weekly chart itself.
CMP 2311
Can be held for a medium to long term perspective.
Note: This is not an investment advice, it is just an educational study from my perspective. I am not SEBI registered.
Talking about fundamental analysis, the stock has a net profit margin which fluctuates between 15-20% on yearly basis which is good for investment. The revenue has been increasing continuously for the past 5 years and the net profit looks good too.
Talking about the technical analysis, the stock is not in the overbought zone and has taken a support on the weekly chart itself.
CMP 2311
Can be held for a medium to long term perspective.
Note: This is not an investment advice, it is just an educational study from my perspective. I am not SEBI registered.
Trade closed: target reached
Target reached successfully and even beyond that. I hope everybody booked their profits today. As the markets are very unstable, I am not taking any new trades. I would advice everyone to do the same but you are free to do whatever you want.
Note: This is not a recommendation and I am not SEBI registered.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.